About ALLERGIKA PHARMA

ALLERGIKA® at a glance

Company founded
Products
Employees
Countries

ALLERGIKA Pharma GmbH was founded in 1991 as a mid-sized German pharmaceutical company headquartered in Wolfratshausen near Munich. It manufactures products to prevent and treat allergies and skin conditions. Of our current team of 70 employees, approximately 13 are in the field, mainly serving allergists, dermatologists, pharmacies, health insurance companies, and patients.

“Our Allergika World – Dream. Dare. Deliver.” is our long-term plan to grow internationally. Our core brand ALLERGIKA® is registered worldwide and distributed in more than ten countries, including the United Arab Emirates, Poland, Switzerland, and several other European countries.

ALLERGIKA®: Uncompromising commitment to skin health

Effective therapies for skin diseases and the best possible care for people with skin problems ­– that is our company mission at ALLERGIKA Pharma. Our activities focus on the skin health of people with allergies, neurodermatitis, as well as dry and sun-sensitive skin. Protecting the sensitive skin of children and babies from the first day of life is also close to our hearts.

Our broad portfolio is based on the expertise and experience we have gained over almost three decades. In addition to dermatological products of pharmaceutical quality for the whole body, our offering also includes textiles like anti-allergenic bedding (encasings) for people with allergies, cast protectors and natural solutions to improve the hygiene of living spaces.

Innovative strength and highest quality from Germany

“Made in Germany” has been the hallmark of quality for all our dermatological products since the company was founded in 1991. It enables us to meet the most demanding pharmaceutical and dermocosmetic requirements. Research and development continue to drive us forward as we develop forward-looking solutions. One example is our modern airless packaging, which protects our oxygen-sensitive hypoallergenic formulations and underlines our commitment to sustainability and environmental protection.
Today, the name ALLERGIKA® is synonymous with tireless efforts to serve people with allergies and skin problems in more than 10 countries. Together with our partners in Southern and Eastern Europe, , the Middle East and Asia, we are committed to the health and well-being of young and older people with skin conditions. Leading dermatologists and paediatricians worldwide recommend ALLERGIKA® in their practices and clinics – a motivator for us to become even better today and tomorrow.

Our milestones

COMPANY FOUNDED

Introduction of ILLA® cast protectors

ALLERGIKA® ANTI-ALLERGENIC BEDDING (ENCASING) LAUNCHED

Our portfolio for people with dust mite allergies has since been expanded to include complementary products such as ALLERGIKA® Travel anti-allergenic sleeping bag and ALLERGIKA® MiteSTOP

ALLERGIKA® THERAPEUTIC SKINCARE LAUNCHED

Our “From Head to Toe” offering includes 30 products across four categories:

  • Neurodermatitis and eczema
  • Irritated, sensitive skin
  • Dry skin
  • Sun protection

2011 - 2013:
THE ALLERGIKA® BRAND IS REGISTERED WORLDWIDE

ALLERGIKA® THERAPEUTIC SKINCARE LAUNCHED IN

  • Austria
  • Hungary
  • Luxembourg
  • Morocco
  • Saudi Arabia

ALLERGIKA® THERAPEUTIC SKINCARE LAUNCHED IN

  • Chile
  • Colombia
  • Croatia
  • Mexixo
  • Rumania
  • Russia
  • Slovenia
  • Slovakia
  • Thailand

ALLERGIKA® TSC LINE LAUNCHED IN

  • Chile
  • Colombia

ALLERGIKA® ENCASINGS LAUNCHED IN

  • Russia
  • Ukraine
  • Belarus
  • Kazakhstan
  • Estonia
  • Lithuania
  • Latvia

ALLERGIKA® TSC LINE LAUNCHED IN

  • Hungary
  • Ukraine

ALLERGIKA® ENCASINGS LAUNCHED IN

  • Czech Republic

ESTABLISHMENT OF A DEDICATED SALES TEAM FOR GERMANY AND AUSTRIA

ALLERGIKA® ENCASINGS LAUNCHED IN

  • Hong Kong
  • Kuwait
  • Singapore

ALLERGIKA Pharma GmbH becomes part of Avia Pharma AB (Sweden)

ALLERGIKA Pharma GmbH becomes part of Avia Pharma AB (Sweden)

Introduction of ILLA® cast protectors

ALLERGIKA® ANTI-ALLERGENIC BEDDING (ENCASING) LAUNCHED

Our portfolio for people with dust mite allergies has since been expanded to include complementary products such as ALLERGIKA® Travel anti-allergenic sleeping bag and ALLERGIKA® MiteSTOP

ALLERGIKA® THERAPEUTIC SKINCARE LAUNCHED

Our “From Head to Toe” offering includes 30 products across four categories:

  • Neurodermatitis and eczema
  • Irritated, sensitive skin
  • Dry skin
  • Sun protection

2011 - 2013:
THE ALLERGIKA® BRAND IS REGISTERED WORLDWIDE

ALLERGIKA® THERAPEUTIC SKINCARE LAUNCHED IN

  • Austria
  • Hungary
  • Luxembourg
  • Morocco
  • Saudi Arabia

ALLERGIKA® THERAPEUTIC SKINCARE LAUNCHED IN

  • Chile
  • Columboa
  • Croatia
  • Mexico
  • Romania
  • Russia
  • Slovenia
  • Slovakia
  • Thailand

ALLERGIKA® TSC LINE LAUNCHED IN

  • Chile
  • Colombia

ALLERGIKA® ENCASINGS LAUNCHED IN

  • Russia
  • Ukraine
  • Belarus
  • Kazakhstan
  • Estonia
  • Litthuania
  • Latvia

ALLERGIKA® TSC LINE LAUNCHED IN

  • Hungary
  • Ukraine

ALLERGIKA® ENCASINGS LAUNCHED IN

  • Czech Republic

ESTABLISHMENT OF A DEDICATED SALES TEAM FOR GERMANY AND AUSTRIA

ALLERGIKA® ENCASINGS LAUNCHED IN

  • Hong Kong
  • Kuwait
  • Singapore

ALLERGIKA Pharma GmbH becomes part of Avia Pharma AB (Sweden)

Kongresse & Veranstaltungen

CPHI, 01.11. -03.11.2022, Frankfurt

Mit einem eigenen Messestand nahm ALLERGIKA Pharma an der weltweit größten Veranstaltung der Pharmabranche teil. Mehr als 100.000 Fachleute der Pharmaindustrie kamen zusammen und nutzten die Messe als Plattform zum Networking und Informationsaustausch.

Arab Health, 30.01.-02.02.2023, Dubai

ALLERGIKA Pharma nahm erstmalig mit einem eigenen Stand an der Arab Health in Dubai teil. Die Arab Health ist die wichtigste Veranstaltung für die Gesundheitsbranche, die eine entscheidende Rolle dabei spielt, regionale und internationale Fachleute des Gesundheitswesens durch Handel und Innovation zusammenzubringen. Insgesamt nahmen 64.000 Besucher und 3.000 Aussteller aus 75 Ländern teil.

BVDD Jahrestagung Westphalen Lippe in Lünen, Atopische Dermatitis, 25.02.23

teil. Es waren insgesamt 135 Ärzte anwesend. Thema der Veranstaltung war unteranderem Berufspolitik und Atopische Dermatitis.

6. Lübecker Update in Lübeck, Entzündliche Hauterkrankungen, 04.03.23

Allergika Pharma nahm mit eigenem Stand am 6. Lübecker Update mit dem Thema „Entzündliche Hauterkrankungen“ teil. Es waren 117 Ärzte in Präsenz und 57 Ärzte online anwesend, ein toller Erfolg.

DERM Frankenthal in Frankenthal, 24.03.23

Allergika Pharma nahm mit eigenem Stand an der DERM in Frankenthal teil. Es waren 2000 Ärzte anwesend. Die Teilnehmer waren nicht nur aus Deutschland, sondern auch aus Belgien, China, Frankreich, Luxemburg, Niederlande, Österreich, Portugal, Schweden, Schweiz, Südkorea und der USA. Zum ersten Mal wurde unser neuer Sonnenschutz Allergika Sun Protect vorgestellt.

Allergika Vertriebstagung in Göttingen, 17.- 19.04.23

Unsere erste Vertriebstagung mit dem Thema Sonnenschutz fand dieses Jahr in Göttingen statt. Es nahmen 12 Außendienstmitarbeiter, 5 interne Mitarbeiter vor Ort, 2 interne Mitarbeiter digital und 3 externe Mitarbeiter teil.

Neuer Vertriebspartner aus Israel,01.05.2023

ALLERGIKA konnte einen neuen Vertriebspartner aus Israel gewinnen. Ab 2024 werden unsere ALLERGIKA® Produkte durch Propharm aus Tel Aviv vertrieben. PROPHARM, ein Familienunternehmen, wurde 1996 gegründet und ist eines der am schnellsten wachsenden Pharmaunternehmen in Israel. Die Firma importiert und vertreibt pharmazeutische Produkte an Krankenhäuser, öffentliche Gesundheitseinrichtungen und private Apotheken. PROPHARMs Erfahrung, Professionalität und Transparenz sind die Schlüsselbegriffe für den Aufbau produktiver und langfristiger Geschäftspartnerschaften. Wir freuen uns über die Zusammenarbeit.

Upcoming News

19th Tegernsee Conference in Bad Wiessee (Germany), Update on Dermatology, 20/10/23

Allergika Pharma will again have a stand at the Tegernsee Conference in Bad Wiessee. The theme „Update on Dermatology“ will provide the participants with insights into the further developed national guidelines. Approximately 80 participants are expected to attend.

CPHI, 24/10 – 26/10, 2023, Barcelona (Spain)

Once again, ALLERGIKA Pharma will have a stand in the world’s largest event for the pharmaceutical industry. With more than 100,000 pharmaceutical industry professionals uniting, the trade fair is a platform for networking and exchanging information.

BVDD Annual Meeting North-Rhine in Moers (Germany), 28/10/23

Allergika Pharma will again have a stand at the annual meeting of the Professional Association of German Dermatologists (Berufsverband der Deutschen Dermatologen) in Moers, Germany. Approximately 100 dermatologists with private practices are expected to attend.

Allergology Basic Course, Centre for Allergology and Rhinology, 18/11/23 in Wiesbaden (Germany)

Allergika Pharma will again have a stand at the Allergology Basic Course, organised by the Centre for Allergology and Rhinology in Mainz. Approximately 50 allergists with private practices are expected to attend.

Arab Health, 29/01 – 01/02, 2024, Dubai (United Arab Emirates)

ALLERGIKA will again have a stand at the premier event for the healthcare industry in the Middle East and North Africa. Arab Health is the most important event for the healthcare industry, playing a crucial role in bringing together regional and international healthcare professionals through trade and innovation.

19. Tegernsee-Konferenz in Bad Wiessee, Update on Dermatology, 20.10.23

Allergika Pharma nimmt auch dieses Jahr wieder mit eigenem Stand an der Tegernsee-Konferenz in Bad Wiessee teil. Unter dem Thema „Update on Dermatology“ werden den Teilnehmern Einblicke in die weiterentwickelten nationalen Leitlinien verschafft. Es werden ca. 80 Teilnehmer erwartet.

CPHI, 24.10. -26.10.2023, Barcelona

Auch in diesem Jahr nimmt ALLERGIKA Pharma an der weltweit größten Veranstaltung der Pharmabranche teil. Mehr als 100.000 Fachleute der Pharmaindustrie kommen zusammen und nutzen die Messe als Plattform zum Networking und Informationsaustausch.

Jahrestagung BVDD Nordrhein in Moers, 28.10.23

Allergika Pharma nimmt auch dieses Jahr wieder mit eigenem Stand an der Jahresverbandstagung der BVDD Nordrhein in Moers teil. Es werden ca. 100 niedergelassene Dermatologen erwartet.

Grundkurs Allergologie in Mainz Zentrum für Allergologie und Rhinologie, 18.11.23 in Wiesbaden

Allergika Pharma nimmt auch dieses Jahr wieder mit eigenem Stand an dem Allergologie Grundkurs, veranstaltet von dem Zentrum für Allergologie und Rhinologie, in Mainz teil. Es werden ca. 50 niedergelassene Allergologen erwartet.

Arab Health, 29.01.-01.02.2024, Dubai

ALLERGIKA nimmt wieder an der wichtigsten Veranstaltung für die Gesundheitsbranche im Arabischen Raum mit einem eignen Messestand in Dubai teil. Die Arab Health ist die wichtigste Veranstaltung für die Gesundheitsbranche, die eine entscheidende Rolle dabei spielt, regionale und internationale Fachleute des Gesundheitswesens durch Handel und Innovation zusammenzubringen.

Quality & Technology

Production & Microbial Protection

Our production is carried out under supervision and in compliance with the highest pharmaceutical standards. Airless packaging provides maximum protection against microorganisms (bacteria, viruses, fungi, mould) and certain allergens (pollen, spores, dust).

Innovation

ALLERGIKA® is a specialist in lipophilic galenic preparations, such as water-in-oil (W/O) emulsions. We develop innovative formulations for sensitive and dry skin to strengthen the skin barrier and provide a pleasant sensation.

Made in Germany

ALLERGIKA® is “Made in Germany”. All our derma products are developed, produced and filled in Germany. We are always in close contact with our production team to ensure the highest quality standards.

Vision - Mission

We aim to become the world’s most respected medical specialists in allergy and dermatology. Our mission is to make the world a healthier place by developing medical solutions for the diagnosis, treatment and prevention of allergies and allergy-related skin diseases.

ALLERGIKA® – What we stand for

Innovative products for the cortisone-free treatment of eczema and neurodermatitis as well as for the basic therapy of sensitive and dry skin (including psoriasis).

  • Products from head to toe
  • A unique concept for sensitive, allergy-prone skin
  • All products are 100% free of fragrances, dyes, preservatives, parabens, natural allergens and the 328 most common allergens according to the German contact allergy group
  • All products have been dermatologically and allergy tested with excellent results, making them particularly suitable for people suffering from allergies and allergy-prone skin
  • Clinically proven efficacy and safety
  • Production in Germany under the most stringent pharmaceutical guidelines

“Made in Germany” has been the hallmark of quality for all our dermatological products since the company was founded in 1991. It enables us to meet the most demanding pharmaceutical and dermocosmetic requirements. Research and development continue to drive us forward as we develop forward-looking solutions. One example is our modern airless packaging, which protects our oxygen-sensitive hypoallergenic formulations and underlines our commitment to sustainability and environmental protection.

Today, the name ALLERGIKA® is synonymous with tireless efforts to serve people with allergies and skin problems in more than 10 countries. Together with our partners in Southern and Eastern Europe, South America, the Middle East and Asia, we are committed to the health and well-being of young and older people with skin conditions. Leading dermatologists and paediatricians worldwide recommend ALLERGIKA® in their practices and clinics – a motivator for us to become even better today and tomorrow.

The name ALLERGIKA® is synonymous with:

  • Our company name
  • Our registered trademark
  • Our products, their application and indications
  • Our patient’s profile
  • Our collective mission as employees

Sustainability

Sustainability

SUSTAINABILITY is a top priority for us! That’s why we use only raw materials derived from renewable plant resources at ALLERGIKA®. Our formulations are continuously tested and updated to ensure potentially undesirable ingredients are removed as quickly as possible.

Sun Protection

Sun care products protect against sunburn and prevent some unpleasant skin problems. However, what is good for our skin can harm the environment. Certain UV filters are suspected of damaging corals and other marine organisms if they are released from the skin into the water while swimming.

For this reason, the UV filters in all our sunscreen products have been selected to be „reef and coral friendly“. They provide all-round sun protection without having a „bleaching“ effect on corals.

Equally important: the UV filters we use do not have a hormonal effect on the human body.

Packaging

Most of our product packaging is made of recyclable PET plastic. This is not only easy to transport and very durable, but also easily recyclable. For many products, we avoid environmentally harmful folding cartons.

Your personal copy of the ALLERGIKA® Newsletter

Stay informed about news, competitions, and product tests!